We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.25B
AUM Growth
-$25.4M
Cap. Flow
+$12.2M
Cap. Flow %
0.29%
Top 10 Hldgs %
16.34%
Holding
741
New
37
Increased
257
Reduced
342
Closed
37

Sector Composition

Rank Sector Weight
1 Technology 21.59%
2 Communication Services 12.14%
3 Industrials 11.8%
4 Healthcare 11.37%
5 Financials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.99T
$122M 2.89%
2,187,624
+569,652
+35% +$29.8M
MSFT icon
2
Microsoft
MSFT
$2.92T
$83.6M 1.97%
601,032
-2,484
-0.4% -$342K
LRCX icon
3
Lam Research
LRCX
$337B
$82M 1.93%
3,546,980
-538,350
-13% -$11.3M
RCL icon
4
Royal Caribbean
RCL
$86.5B
$73.3M 1.73%
676,645
-22,664
-3% -$2.5M
INXN
5
DELISTED
Interxion Holding N.V.
INXN
$62.5M 1.47%
767,595
-39,302
-5% -$3.06M
QRVO icon
6
Qorvo
QRVO
$8.09B
$58.3M 1.37%
786,124
-35,787
-4% -$2.6M
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$56.6M 1.33%
190,582
+6,230
+3% +$1.84M
JPM icon
8
JPMorgan Chase
JPM
$950B
$53M 1.25%
449,998
+707
+0.2% +$80K
LITE icon
9
Lumentum
LITE
$50.7B
$51M 1.2%
952,287
-42,733
-4% -$2.41M
VB icon
10
Vanguard Small-Cap ETF
VB
$80.2B
$50.9M 1.2%
330,934
-493
-0.1% -$76.4K
CGNX icon
11
Cognex
CGNX
$10B
$50.5M 1.19%
1,028,721
-50,680
-5% -$2.29M
PPLI
12
People Inc
PPLI
$3.13B
$49.2M 1.16%
1,262,055
-65,741
-5% -$2.81M
CONE
13
DELISTED
CyrusOne Inc Common Stock
CONE
$48.2M 1.14%
609,314
-31,054
-5% -$2.07M
IONS icon
14
Ionis Pharmaceuticals
IONS
$9.14B
$46M 1.08%
767,960
-32,308
-4% -$2.11M
TRMB icon
15
Trimble
TRMB
$13.6B
$45.2M 1.06%
1,164,368
-57,205
-5% -$2.3M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$72.9B
$43M 1.01%
154,960
-6,944
-4% -$2.05M
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
$42.7M 1.01%
499,936
-92,063
-16% -$6.75M
AMBA icon
18
Ambarella
AMBA
$3.03B
$41.4M 0.97%
658,309
-32,500
-5% -$1.69M
V icon
19
Visa
V
$697B
$40.4M 0.95%
235,046
-1,558
-0.7% -$278K
CMI icon
20
Cummins
CMI
$88.5B
$38.3M 0.9%
235,203
-8,781
-4% -$1.4M
LVS icon
21
Las Vegas Sands
LVS
$32B
$37.7M 0.89%
652,399
-20,274
-3% -$1.18M
HXL icon
22
Hexcel
HXL
$8.3B
$36.4M 0.86%
442,864
-22,739
-5% -$1.86M
MRK icon
23
Merck
MRK
$326B
$36.3M 0.86%
451,956
-117,942
-21% -$9.45M
KSU
24
DELISTED
Kansas City Southern
KSU
$36M 0.85%
270,396
-13,797
-5% -$1.72M
CMCSA icon
25
Comcast
CMCSA
$85.8B
$35.1M 0.83%
779,428
-1,956
-0.3% -$86.7K

Similar funds

Pinnacle Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Pinnacle Associates held 741 positions worth $4.25B, down 0.6% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Pinnacle Associates's Q3 2019 filing shows 37 new, 257 increased, 342 reduced and 37 closed positions. Its largest new stake was Aerie Pharmaceuticals: 454,750 shares worth $8.74M. The largest sale was Array Biopharma Inc, an estimated $38.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Communication Services and Industrials.

  • Pinnacle Associates's largest Q3 2019 buy was Aerie Pharmaceuticals: 454,750 shares worth $8.74M.
  • Pinnacle Associates added most to Apple in Q3 2019, an estimated $29.8M increase.
  • Pinnacle Associates's biggest Q3 2019 reduction was Lam Research, cutting an estimated $11.3M.
  • Pinnacle Associates fully exited Array Biopharma Inc in Q3 2019, selling an estimated $38.8M.
  • Pinnacle Associates's ten largest holdings make up 16% of its $4.25B portfolio in Q3 2019.
  • Pinnacle Associates opened 37 new positions and closed 37 in Q3 2019.
  • Pinnacle Associates's portfolio value fell 0.6% quarter-over-quarter to $4.25B.

Based on Pinnacle Associates's 13F filing for Q3 2019, filed 8 Nov 2019.